357 related articles for article (PubMed ID: 23036576)
1. Utility of choline positron emission tomography/computed tomography for lymph node involvement identification in intermediate- to high-risk prostate cancer: a systematic literature review and meta-analysis.
Evangelista L; Guttilla A; Zattoni F; Muzzio PC; Zattoni F
Eur Urol; 2013 Jun; 63(6):1040-8. PubMed ID: 23036576
[TBL] [Abstract][Full Text] [Related]
2. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis.
Evangelista L; Zattoni F; Guttilla A; Saladini G; Zattoni F; Colletti PM; Rubello D
Clin Nucl Med; 2013 May; 38(5):305-14. PubMed ID: 23486334
[TBL] [Abstract][Full Text] [Related]
3. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
Evangelista L; Zattoni F; Karnes RJ; Novara G; Lowe V
Nucl Med Commun; 2016 Dec; 37(12):1223-1231. PubMed ID: 27551835
[TBL] [Abstract][Full Text] [Related]
5. [11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
Schumacher MC; Radecka E; Hellström M; Jacobsson H; Sundin A
Scand J Urol; 2015 Feb; 49(1):35-42. PubMed ID: 25001948
[TBL] [Abstract][Full Text] [Related]
6. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
7. The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysis.
Umbehr MH; Müntener M; Hany T; Sulser T; Bachmann LM
Eur Urol; 2013 Jul; 64(1):106-17. PubMed ID: 23628493
[TBL] [Abstract][Full Text] [Related]
8. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymph node uptake in patients with prostate carcinoma on F18-choline PET/CT.
Rietbergen DD; van der Hiel B; Vogel W; Stokkel MP
Nucl Med Commun; 2011 Dec; 32(12):1143-7. PubMed ID: 22045476
[TBL] [Abstract][Full Text] [Related]
10. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
[TBL] [Abstract][Full Text] [Related]
11. Final analysis of a prospective trial on functional imaging for nodal staging in patients with prostate cancer at high risk for lymph node involvement.
Van den Bergh L; Lerut E; Haustermans K; Deroose CM; Oyen R; Isebaert S; Budiharto T; Ameye F; Mottaghy FM; Bogaerts K; Van Poppel H; Joniau S
Urol Oncol; 2015 Mar; 33(3):109.e23-31. PubMed ID: 25655681
[TBL] [Abstract][Full Text] [Related]
12. Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Heck MM; Souvatzoglou M; Retz M; Nawroth R; Kübler H; Maurer T; Thalgott M; Gramer BM; Weirich G; Rondak IC; Rummeny EJ; Schwaiger M; Gschwend JE; Krause B; Eiber M
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):694-701. PubMed ID: 24297503
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic efficacy of [11C]choline positron emission tomography/computed tomography compared with conventional computed tomography in lymph node staging of patients with bladder cancer prior to radical cystectomy.
Maurer T; Souvatzoglou M; Kübler H; Opercan K; Schmidt S; Herrmann K; Stollfuss J; Weirich G; Haller B; Gschwend JE; Schwaiger M; Krause BJ; Treiber U
Eur Urol; 2012 May; 61(5):1031-8. PubMed ID: 22196847
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of choline PET/CT and MRI in the diagnosis of lymph node metastases in patients with prostate cancer.
Huang SM; Yin L; Yue JL; Li YF; Yang Y; Lin ZC
Medicine (Baltimore); 2018 Dec; 97(50):e13344. PubMed ID: 30557983
[TBL] [Abstract][Full Text] [Related]
15. State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer.
Vagnoni V; Brunocilla E; Bianchi L; Porreca A; Borghesi M; Pultrone CV; Angelo P; Chessa F; Ceci F; Mengoni F; Dababneh H; Castellucci P; Fanti S; Martorana G; Schiavina R
Arch Esp Urol; 2015 Apr; 68(3):354-70. PubMed ID: 25948806
[TBL] [Abstract][Full Text] [Related]
16. PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.
Fanti S; Minozzi S; Castellucci P; Balduzzi S; Herrmann K; Krause BJ; Oyen W; Chiti A
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):55-69. PubMed ID: 26450693
[TBL] [Abstract][Full Text] [Related]
17. 18 F-prostate specific membrane antigen positron emission tomography/computerized tomography for lymph node staging in medium/high risk prostate cancer: A systematic review and meta-analysis.
Lv Z; Song L; Wang M; Hou H; Li H; Wang X; Wang J; Wang J; Liu M
Chin Med J (Engl); 2024 Apr; 137(8):949-958. PubMed ID: 37690993
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic relevance of choline-PET / CT in patients with prostate cancer].
Zengerling F; Schrader AJ; Schrader M; Jentzmik F
Aktuelle Urol; 2012 Jan; 43(1):49-54. PubMed ID: 21769763
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of
Kim SJ; Lee SW
Br J Radiol; 2019 Sep; 92(1101):20190193. PubMed ID: 31265330
[TBL] [Abstract][Full Text] [Related]
20. 11C-Choline PET/CT in the primary diagnosis of prostate cancer: impact on treatment planning.
Garcia JR; Jorcano S; Soler M; Linero D; Moragas M; Riera E; Miralbell R; Lomeña F
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):342-50. PubMed ID: 24844254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
